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Imaging Findings of Intrahepatic Bile
Duct Adenoma (Peribiliary Gland
Hamartoma): a Case Report and
Literature Review
Intrahepatic bile duct adenoma is a rare benign epithelial hepatic tumor derived
from bile duct cells. We report the imaging findings of a patient with bile duct ade-
noma, which appeared as a small heterogeneously enhancing mass with focal
small cystic change on CT and MRI. Follow-up images at seven months showed
a slight increase in tumor size, which could be partly explained by intratumoral
hemorrhage on pathologic examination. Although rare, bile duct adenoma should
be considered as a differential diagnosis of a small hypervascular tumor located
in the periphery of liver. Focal cystic change and intratumoral hemorrhage may
occur.
ntrahepatic bile duct adenoma (BDA) is a rare benign epithelial liver
tumor derived from bile duct cells. BDA represents about 1.3% of all
primary liver tumors and it is mainly found incidentally on the surface of
the liver at laparotomy or autopsy (1-5). Grossly, BDA is a well-circumscribed,
however not encapsulated mass ranging in size from 1 to 20 mm (1). Histologically,
BDA is characterized by a confluent proliferation of bile ductules in a connective
tissue stroma which show variable degrees of inflammation and fibrosis. BDA has
been reported to show benign behavior and have limited growth potential (1, 4).
We report imaging findings of a case of BDA showing mild lesion enlargement on
seven-month follow-up images, leading to the preoperative diagnosis of a possible
malignant tumor. To the best of our knowledge, this is the first case studied with
triphasic dynamic contrast-enhanced CT scans and gadolinium-ethoxybenzyl-diethyl-
enetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI.
CASE REPORT
A 59-year-old female patient was referred to our hospital for evaluation of a hepatic
mass. The lesion was incidentally found during ultrasound screening at a local clinic.
The patient had no symptoms or history of viral hepatitis or excessive alcohol intake.
A physical examination and laboratory findings were unremarkable.
CT scans were performed to evaluate the hepatic mass. Unenhanced CT scan
showed a well-defined low density mass measuring about 1.7 cm in the periphery of
the posteroinferior segment of the right lobe of the liver (Fig. 1A). On dynamic
contrast-enhanced CT, the mass revealed heterogeneous enhancement with an internal
non-enhancing small cystic portion on the hepatic arterial phase (Fig. 1B) and persis-
tent enhancement on portal venous and equilibrium phases (Fig. 1C). No other mass
was found in the liver. Initially, we diagnosed the mass as a benign lesion such as
angiomyolipoma with little fat component or inflammatory pseudotumor. However,
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Ithe possibility of malignant lesions such as cholangiocarci-
noma or atypical hepatocellular carcinoma could not be
excluded. Follow-up CT scan was performed two months
later and the imaging findings did not change compared to
the initial CT scans. However, follow-up CT at seven
months revealed a slight increase in the diameter of the
mass from 1.7×1.2 cm to 2.1×1.8 cm, with an increase in
the size of the internal enhancing portion (Fig. 1D). We
performed liver MRI for further evaluation. MRI revealed
that the mass showed heterogeneous high signal intensity
on T2-weighted images (Fig. 1E) and low signal intensity
on T1-weighted images (Fig. 1F). Contrast-enhanced MRI
was performed using a breath-hold 3D gradient echo
sequence with a fat saturation sequence, after an
intravenous bolus injection of 0.025 mmol Gadoxetic acid
(Gd-EOB-DTPA; Primovist, Schering AG, Berlin,
Germany) per kilogram of body weight followed by a
saline flush of 30 mL. The mass showed heterogeneous
enhancement and focal cystic change on hepatic arterial
phase (Fig. 1G, H), relative hypointensity in comparison
with the normal liver parenchyma on portal venous and
equilibrium phases (Fig. 1I), and lower signal intensity on
hepatobiliary phase obtained 20 minutes after contrast
injection (Fig. 1J). Considering the duration of the tumor
growth period (7 months), it was difficult to rule out the
possibility of low grade malignancy. The patient opted for
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Fig. 1. Dynamic contrast-enhanced CT scans and follow-up MR images in 59-year-old woman with intrahepatic bile duct adenoma.
A. Unenhanced CT scan shows well-defined low density mass measuring about 1.7 cm in periphery of posteroinferior segment of right
hepatic lobe (arrow). 
B. Dynamic contrast-enhanced CT performed on mass shows heterogeneous enhancement (arrow) during hepatic arterial phase. Focal
non-enhancing cystic portion is seen in anterior portion of mass.
C. On equilibrium phase, mass shows relatively persistent enhancement (arrow).
D. On equilibrium phase of follow-up CT scans obtained after seven months, tumor is slightly enlarged, measuring about 2.1 cm in
diameter.
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Fig. 1. Dynamic contrast-enhanced CT scans and follow-up MR images in 59-year-old woman with intrahepatic bile duct adenoma.
E. Coronal T2-weighted half fourier acquisition single shot turbo spin echo (HASTE) image revealed that lesion has heterogeneous high
signal intensity (arrow) with several small areas of bright signal intensity similar to that of fluid.
F. On T1-weighted image, lesion shows homogeneous hypointensity (arrow).
G. On dynamic contrast-enhanced T1-weighted images with fat saturation after administration of Gd-EOB-DTPA, upper portion of mass
shows focal non-enhancing cystic portion with heterogeneous enhancement in remaining portion (arrow) during hepatic arterial phase.
H. Lower portion of mass located 8 mm caudad to G shows heterogeneous enhancement during hepatic arterial phase.
I. On equilibrium phase, mass shows relative hypointensity in comparison with normal liver parenchyma (arrow).
J. On hepatobiliary phase obtained 20 minutes after contrast injection, mass shows distinct low signal intensity (arrow).
IJresecting the mass and hepatic segmentectomy was
performed.
Gross specimen showed a well-circumscribed, non-
encapsulated, firm, yellowish white mass with multiple
cystic changes and a hemorrhagic component (Fig. 1K).
Microscopically, the mass consisted of a densely packed
proliferation of simple tubular ducts with cuboidal cells
embedded in a moderate amount of fibrous stroma (Fig.
1L). The cuboidal cells were uniform and lacked nuclear
pleomorphism as well as hyperchromasia without definite
mitoses and vascular or lymphatic invasion. The
background liver parenchyma showed no fibrosis or fatty
change. An immunohistochemical examination
demonstrated positive staining for cytokeratin 7 and
cytokeratin 19 as well as negative staining for p 53.
Expression of cytokeratin 7 and cytokeratin 19
represented the bile duct origin tumor, while the negative
reactivity for p 53 helped distinguish BDA from the
metastatic pancreatic adenocarcinoma in the liver (6). The
histologic diagnosis was an intrahepatic BDA.
DISCUSSION
Intrahepatic BDA is a rare benign epithelial tumor of the
liver that is usually incidentally found at surgery or
autopsy (1-4). Its incidence was reported to make up 1.3%
of primary liver tumors (2). Craig et al. (3) reported only
five cases of intrahepatic BDA in 50,000 autopsies, and
until now, Allaire et al. (1) have reported the 152 cases
between 1943 and 1986, which is the largest series of
BDA. Of the 152 cases, most BDAs were asymptomatic
nodules discovered incidentally on the surface of the liver
during intra-abdominal surgery in 103 cases or at autopsy
in 49 cases. They were usually subcapsular, ranging in size
from 1 to 20 mm (mean, 5.8 mm), and most of them were
less than 1 cm in diameter. The majority of BDAs occurred
in individuals between the ages of 20 and 70 years with a
mean age of 55 years and no significant difference in sex
distribution (1). BDA is a usually solitary nodule, but may
occur as multiple nodules throughout the liver (5, 7).
Macroscopically, BDA is a solitary, well-circumscribed,
firm, gray-white or tan, subcapsular nodule (8).
Microscopically, BDAs are composed of the proliferation
of disorganized mature peribiliary gland acini and ductules
within a variable amount of connective tissue stroma
showing signs of chronic inflammation and collagenization
(1, 4). The cells of the bile ductules have low mitotic
activity (1).
There has been considerable controversy in the origin,
pathogenesis and nomenclature of BDA. In the early litera-
ture, BDA was regarded as a true neoplasm and has been
called a cholangioma, benign cholangioma, or cholan-
gioadenoma (5). It has also been confused with bile duct
hamartoma (von Meyenberg complex) or intrabiliary BDA
in some reports (5, 9, 10); however, BDA is a pathologi-
cally distinct entity (11). Microscopically, BDA is distin-
guished from a bile duct hamartoma by its lack of intralu-
minal bile and the compact nature of its proliferation (8).
Although the pathogenesis of BDA is still under discus-
sion, the most accepted pathogenesis of BDA, based on
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Fig. 1. Dynamic contrast-enhanced CT scans and follow-up MR images in 59-year-old woman with intrahepatic bile duct adenoma.
K. Gross specimen shows well-circumscribed, non-encapsulated, yellowish white, subcapsular mass (white arrows). Multiple cystic
changes (arrowhead) are seen in mass and focal hemorrhagic component (open arrow) is combined.
L. Microscopically, mass consists of densely packed proliferation of simple tubular ducts (arrow) combined with hemorrhage (H).
Cuboidal epithelium resembles that of interlobular bile ducts without cell atypia or mitotic activity (Hematoxylin & Eosin staining, ×200).
KLimmunohistochemical studies, is a reactive process to a
focal bile ductular injury caused by trauma or inflamma-
tion (1). Recently, a study demonstrated a similarity in the
secretory gland cell phenotype between BDA and peribil-
iary glands, suggesting that BDA represents disorganized
peribiliary glands (9). In BDA, the acini and tubules fail to
organize into a mature gland, draining into a bile duct,
possibly because of the absence of appropriate mesenchy-
mal-epithelial signaling. The authors of the aforementioned
study suggested that BDA is a misnomer and BDA should
be called a peribiliary gland hamartoma (9).
There have been four reports on the radiological features
of BDA, of which two are in the Japanese literature. In
those four reports, a total of six BDAs were included.
Adding our case, we summarized the radiologic features of
seven BDAs. The masses were measured from 4 to 21 mm
in size (mean: 12 mm) and all lesions were located in the
subcapsular or surface of the liver. Four lesions were found
during the evaluation of chronic hepatitis and three lesions
were found incidentally.
Ultrasound was performed in five cases, in which three
cases showed an echogenic nodule with or without a
hypoechoic rim (4, 12, 13), while two lesions were not
detected by ultrasound. On nonenhanced CT performed in
four cases, two lesions showed hyperdense areas in the
lesion, probably due to calcifications within the tumor (12,
14). On MRI performed in five cases, three lesions, includ-
ing our case, showed hypointensity on T1-weighted image
(WI) and hyperintensity on T2-WI (4). One lesion showed
hyperintensity both on T1- and T2-WI (4), while the other
showed hypointensity both on T1- and T2-WI, probably
due to calcification (7). Although various imaging
techniques were used in the previous reports from differ-
ent institutions, most BDAs showed hypervascular charac-
teristics consisting of prolonged enhancement on dynamic
contrast-enhanced CT and MRI, hepatic artery angiogra-
phy, CT hepatic arteriography, and CT during arterial
portography. Delayed or prolonged enhancement in
dynamic studies of CT and MRI may be due to the fibrous
stroma within the tumor (15). Our case showed relative
hypointensity on equilibrium phase and distinct hypointen-
sity on hepatobiliary phase of dynamic contrast-enhanced
MRI, which may be explained by the use of Gd-EOB-
DTPA. Since it is distinct from extracellular fluid contrast
agents that rapidly equilibrate with the extravascular space
following injection, Gd-EOB-DTPA is initially distributed
in the extracellular fluid compartment, but is subsequently
taken up by functioning hepatocytes and is excreted in the
bile (16). Therefore, our case showed low signal intensity
compared to background liver enhancement on equilib-
rium phase of GD-EOB-DTPA-enhanced MRI. Since BDA
may have various amounts of fibrous stroma, the signal
intensity on T2-weighted MR images and enhancement
features on dynamic studies of CT and MRI may be
variable according to the amount of fibrous stroma (17). 
Our case was a well-defined hypervascular mass in the
subcapsular portion of the liver with prolonged enhance-
ment on CT, as previously reported. The previously
unreported feature of our case is a focal cystic change in
the tumor and increase in size seen in images obtained at
the 7-month follow-up point. Although benign tumors may
have slow growth potential, the possibility of a low grade
malignant tumor cannot be excluded by the imaging
findings. Pathologic findings showed multifocal cystic
changes and focal hemorrhage within the lesion, which are
thought to be the cause of tumor growth.
Previous reports represented that BDA was difficult to
detect due to its small size and peripheral location (4, 17).
However, due to recently improved imaging techniques
and increased use of cross sectional imaging, especially for
patients with chronic hepatitis, more BDAs can be identi-
fied on imaging studies. Therefore, radiologists should be
familiar with the imaging findings of BDAs, even though
the accurate diagnosis of BDA still requires a histopatho-
logic examination.
In summary, we experienced a case of BDA showing
internal cystic change and slight tumor enlargement at a 7-
month follow-up time. The mass showed heterogeneous
enhancement during the hepatic arterial phase of dynamic
CT and MRI. The mass showed distinct hypointensity on
hepatobiliary phase obtained 20 minutes after administra-
tion of Gd-EOB-DTPA. BDA should be considered in the
differential diagnosis of a small hypervascular tumor
located in the subcapsular portion of liver. Focal cystic
changes and intratumoral hemorrhage may occur.
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